Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 59,666
- 试验地点
- 5
- 主要终点
- All-cause, Pregnancy-related Mortality
研究概览
简要总结
The purpose of this trial is to determine whether providing women with a weekly oral supplement of vitamin A, either preformed or as beta-carotene, at a dosage equivalent to a recommended intake from early pregnancy through three months postpartum, can reduce the risk of maternal mortality, fetal loss, or infant mortality.
详细描述
Maternal mortality and vitamin A deficiency coexist in rural South Asia. In Nepal, weekly supplementation with vitamin A or beta-carotene during the child-bearing years reduced all-cause maternal mortality and, in night blind women, also infant mortality. The present trial is testing the efficacy of the same supplements from ~9 weeks' gestation to 12 weeks postpartum. The planned sample size is 68,000 pregnancies. It is being conducted in 19 rural unions, covering an area of ~750 sq km with a population of ~580,000 in Gaibandha and Southern Rangpur Districts in Northern Bangladesh. The study area was mapped as 596 "sectors" (unit of randomization), each comprising 200-275 households; ~135,000 houses were numerically addressed and, at the outset, 103,000 women were listed. Women are visited at home every 5 weeks by 596 trained female staff to detect pregnancy by a combination of menstrual history and urine testing. Newly married women are prospectively enlisted for pregnancy surveillance. Following informed consent urine-positive (pregnant) women detected during surveillance are enrolled to receive weekly a capsule containing 7000 retinol equivalents of preformed vitamin A, 42 mg of beta-carotene or placebo. Vital events are recorded weekly through 3 months postpartum. Trained interviewers conduct maternal nutritional and health and household socioeconomic assessments in the 1st trimester. At 3 months postpartum, interviewers assess both mother and infant for health and nutritional status, including apparent birth defects that are later physician-confirmed. An additional home health assessment occurs at 6 months post partum, and vital status is recorded for mother and infant at one year postpartum. A ~3% subsample of enrolled pregnant women participate in a substudy involving enhanced clinical, anthropometric, biochemical, body compositional, morbidity and interview-based assessment protocols in the 1st, 2nd and 3rd trimesters, and at 3 months post-partum. Reported maternal and infant deaths are verified and causes ascertained during "verbal autopsy" interviews with family members of the deceased.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 15 Years 至 49 Years(Child, Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Married women of reproductive age
- •First pregnancy during time period of trial
排除标准
- •Premenarchial girls
- •Married women with a previous pregnancy enrolled into the trial
- •Previously married women who have moved into the study area
- •Single women (never married, widowers)
- •Women who are sterilized (or whose husbands are sterilized)
- •Menopausal women
结局指标
主要结局
All-cause, Pregnancy-related Mortality
时间窗: Deaths during pregnancy through 12 weeks postpartum
Mortality evaluated on intent-to-treat basis
次要结局
- All-cause 3-month Infant Mortality(Deaths through the 1st 12 weeks of life)
- Maternal Morbidity, Including Obstetric Complications(through the 1st 24 weeks following termination of pregnancy)
- Gestational Age at Birth(within 24 weeks after birth)
- Fetal Growth and Postnatal Infant Growth Through Three Months of Age(through the 1st 12 weeks after birth)
- Infant Morbidity Through 3 Months of Age(within 24 weeks after birth)
- Plasma Beta-carotene in the Third Trimester of Pregnancy(Nutritonal Status of the Mother)(Third trimester of pregnancy (about the 32nd week of gesatation))
- Plasma Retinol at the Third Trimester of Pregnancy (Nutritional Status of the Mother)(Third trimester of pregnancy (about the 32nd week of gestation))
研究者
Keith P. West
Professor
Johns Hopkins Bloomberg School of Public Health
